Lactobacillus rhamnosus ATCC 7469 exopolysaccharides synergizes with low level ionizing radiation to modulate signaling molecular targets in colorectal carcinogenesis in rats

Biomedicine and Pharmacotherapy

Volumn 92, Issue , 2017, Pages 384-393

  Zahran, Walid E ^a   Elsonbaty, Sawsan M ^b   Moawed, Fatma S M ^b  

^a Ain Shams University   (Egypt)

^b NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY   (Egypt)

Author keywords

Cell signaling; Colon cancer; Inflammation; Ionizing radiation; Lactobacillus rhamnosus ATCC 7469; Oxidative stress

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CYCLOOXYGENASE 2; DIMETHYLHYDRAZINE; EXOPOLYSACCHARIDE; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT3 PROTEIN; SUPEROXIDE DISMUTASE; BACTERIAL POLYSACCHARIDE; EXOPOLYSACCHARIDE, BACILLUS;

ANAPLASTIC CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BACTERIAL STRAIN; CANCER CONTROL; CANCER INHIBITION; CARCINOGENESIS; COLON TISSUE; COLORECTAL CANCER; COLORECTAL CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; GAMMA RADIATION; GENE EXPRESSION; GOBLET CELL; HISTOLOGY; INFLAMMATION; IONIZING RADIATION; LACTOBACILLUS RHAMNOSUS; MALE; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; RAT; WESTERN BLOTTING; ANIMAL; COLORECTAL TUMOR; DRUG EFFECTS; METABOLISM; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; RADIATION RESPONSE; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOGENESIS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; LACTOBACILLUS RHAMNOSUS; MALE; POLYSACCHARIDES, BACTERIAL; RADIATION, IONIZING; RATS; SIGNAL TRANSDUCTION;

EID: 85019925799     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.05.089     Document Type: Article

References (61)

1. Gado, A., Ebeid, B., Abdelmohsen, A., et al. Colorectal cancer in Egypt is commoner in young people: is this cause for alarm. Alexandria J. Med. 50 (2014), 197–201.
2. Torre, L.A., Bray, F., Siegel, R.L., et al. Global cancer statistics 2012. CA Cancer J. Clin. 65 (2015), 87–108.
3. Ambalam, P., Raman, M., Purama, R.K., et al. Probiotics, prebiotics and colorectal cancer Prevention. Best Prac. Res. Clin. Gastroenterol., 30, 2016, 119e131.
4. Aran, V., Victorino, A.P., Thuler, L.C., et al. Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin. Colorec Cancer 15:3 (2016), 195–203.
5. Neumaie, T., Swenson, J., Pham, C., et al. Evidence for formation of DNA repair centers and dose-response non linearity in human cells. PNAS 109 (2012), 443–448.
6. Umesalma, S., Sudhandiran, G., Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. Eur. J. Pharmacol. 660 (2011), 249–258.
7. Thakur, V.S., Deb, G., Babcook, M.A., et al. Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention. AAPS J. 16 (2014), 151–163.
8. Yao, Y., Xue, P., Zhu, Y., et al. Antioxidant and immunoregulatory activity of polysaccharides from adzuki beans (Vigna angularis). Food Res Inter. 77 (2015), 251–256.
9. Uccello, M., Malaguarnera, G., Basile, F., et al. Potential role of probiotics on colorectal cancer prevention. BMC Surg., 12, 2012, S35.
10. Song, S., Oh, S., Lim, K.T., The proteins (12 and 15 kDa) isolated from heat-killed Lactobacillus plantarum L67 induces apoptosis in HT-29 cells. Cell Biochem. Funct., 33, 2015, 89e96.
11. WHO, Food and Agriculture Organization of the United Nations. Evaluation of Health and Nutritional Porperties of Probiotics in Food Including Powder Milk with Live Lactic and Bacteria, Cordoba. 2001 (http://www.who.int/foodsafety/publications/fsmanagement/probiotics/en/index.html).
12. Jorjão, A.L., de Oliveira, F.E., Leão, M.V.P., Live and heat-killed Lactobacillus rhamnosus ATCC 7469 may induce modulatory cytokines profiles on macrophages RAW 264.7. Sci. World J., 2015, 1–6 (Article ID 716749).
13. Zhang, W., Zhu, Y.H., Yang, J.C., Yang, G.Y., Zhou, D., Wang, J.F., A selected Lactobacillus rhamnosus strain promotes EGFR-Independent akt activation in an enterotoxigenic escherichia coli K88-Infected IPEC-J2 cell model. PLoS One, 10(4), 2015, e0125717.
14. Banck, M.S., Kanwar, R., Kulkarni, A.A., Boora, G.K., Metge, F., Kipp, B.R., et al. The genomic landscape of small intestine neuroendocrine tumors. J. Clin. Invest. 123 (2013), 2502–2508.
15. Park, H.S., Yun, Y., Kim, C.S., et al. A critical role for AKT activation in protecting cells from ionizing radiation-induced apoptosis and the regulation of acinus gene expression. EJCB 88 (2009), 563–575.
16. Altomare, D.A., Testa, J.R., Perturbations of the AKT signaling pathway in human cancer. Oncogene 24 (2005), 7455–7464.
17. Dent, P., Yacoub, A., Fisher, P.B., et al. MAPK pathways in radiation responses. Oncogene 22 (2003), 5885–5896.
18. Ng, I.S., Xue, C., Enhanced exopolysaccharide production and biological activity of Lactobacillus rhamnosus ZY with calcium and hydrogen peroxide. Process Biochem. 52 (2017), 295–304.
19. Jaferian, S., Negahdari, B., Eatemadi, A., Colon cancer targeting using conjugates biomaterial 5-flurouracil. Biomedicine & Pharmacotherapy 84 (2016), 780–788.
20. Weng, W., Feng, J., Qin, H., et al. Molecular therapy of colorectal cancer: progress and future directions. Int. J. Cancer 136 (2015), 493–502.
21. Aachary, A.A., Gobinath, D., Srinivasan, K., et al. Protective effect of xylooligosaccharides from corncob on 1, 2-dimethylhydrazine induced colon cancer in rats. Bioactive Carbohydrates and Dietary Fibers 5 (2015), 146–152.
22. Phamp, L., Dupont, I., Roy, D., et al. Production of exopolysaccharide by Lactobacillus rhamnosus R and analysis of its enzymatic degradation during prolonged fermentation. Appl Environ Micro. 66:6 (2000), 2302–2310.
23. Sengül, N., Işık, S., Aslım, B., et al. The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis. Dig. Dis. Sci. 56 (2011), 707–714.
24. Vinderola, G., Perdigo, G., Duarte, J., Farnworth, E., Matar, C., Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity. Cytokine 36 (2006), 254–260.
25. Frey, B., Hehlgans, S., Rodel, F., Gaipl, U.S., Modulation of inflammation by low and high doses of ionizing radiation: implications for benign and malign diseases. Cancer Lett. 368:2 (2015), 230–237.
26. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979), 351–358.
27. Paglia, D.E., Valentine, W.N., Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 70, 1967, 158.
28. Minami, M., Yoshikawa, H., A simplified assay method of superoxide dismutase activity for clinical use. Clin. Chim. Acta 92:3 (1979), 337–342.
29. Chomczynski, P., A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15 (1993), 532–537.
30. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976), 248–254.
31. Pfaffl, M.W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001), 2002–2007.
32. Banchroft, J.D., Stevens, A., Turner, D.R., Theory and Practice of Histological Techniques. fourth edition, 1996, Churchil Livingstone, New York, London, San Francisco, Tokyo.
33. Nirmala, P., Ramanathan, M., Effect of kaempferol on lipid peroxidation and antioxidant status in 1,2-dimethyl hydrazine induced colorectal carcinoma in rats. Eur. J. Pharmacol. 654 (2011), 75–79.
34. Jrah-Harzallah, H., Ben-Hadj-Khalifa, S., Almawi, W.Y., et al. Effect of thymoquinone on 1,2-dimethyl-hydrazine-induced oxidative stress during initiation and promotion of colon carcinogenesis. Eur. J. Cancer 49 (2013), 1127–1135.
35. Gibellini, L., Pinti, M., Nasi, M., et al. Interfering with ROS metabolism in cancer cells: the potential role of quercetin. Cancers 2 (2010), 1288–1311.
36. Lall, R., Ganapathy, S., Yang, M., et al. Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response. Cell Death Differ. 21 (2014), 836–844.
37. Gamallat, Y., Meyiah, A., Kuugbee, E.D., et al. Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomedicine & Pharmacotherapy 83 (2016), 536–541.
38. Wang, D., Xia, D., DuBois, R.N., The crosstalk of PTGS2 and EGF signaling pathways in colorectal cancer. Cancers 3 (2011), 3894–3908.
39. Colussi, D., Brandi, G., Bazzoli, F., et al. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int. J. Mol. Sci. 14 (2013), 16365–16385.
40. Grossi, V., Peserico, A., Tezil, T., Simone, C., p38(MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. World J. Gastroenterol. 20:29 (2014), 9744–9758.
41. Depre, M., Van Hecken, A., Verbesselt, R., et al. Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in man. Int. J. Clin. Pharmacol. Res. 16 (1996), 1–8.
42. Corvinus, F.M., Orth, C., Moriggl, R., et al. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 7 (2005), 545–555.
43. Niu, G., Wright, K.L., Huang, M., et al. Constitutive STAT3 activity upregulates VEGF expression and tumor angiogenesis. Oncogene 21 (2002), 2000–2008.
44. Wei, W.D., Le, X., Zheng, L., et al. STAT3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastatis. Oncogene 22 (2003), 319–329.
45. Powell, S.M., Zilk, N., Beazer-Barclay, Y., et al. APC mutations occur early during colorectal tumorigenesis. Nature 359 (1992), 235–237.
46. Huelsken, J., Birchmeier, W., New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 11 (2001), 547–553.
47. Lee, H.K., Choi, Y.S., Park, Y.A., et al. Modulation of oncogenic transcription and alternative splicing by β-catenin and an RNA aptamer in colon cancer cells. Cancer Res. 66 (2006), 10560–10566.
48. Flanagan, L., Meyer, M., Fay, J., et al. Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: caspase-3 inhibition as a therapeutic approach. Cell Death Dis., 7, 2016, e2087.
49. Zhang, D., Li, Y.H., Mi, M., et al. Modified apple polysaccharides suppress the migration and invasion of colorectal cancer cells induced by lipopolysaccharide. Nutr. Res. 33 (2013), 839–848.
50. Shin, J.S., Yun, C.H., Cho, Y.W., et al. Indole-containing fractions of brassica rapa inhibit inducible nitric oxide synthase and pro-inflammatory cytokine expression by inactivating nuclear factor-kappa B. J. Med. Food 14 (2011), 1527–1537.
51. O'Neill, G.P., Ford-Hutchinson, A.W., Expression of RNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330 (1993), 156–160.
52. Rigas, B., Goldman, I.S., Levine, L., Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122 (1993), 518–523.
53. Sano, H., Kawahito, Y., Wilder, R.L., et al. Expression of cyclooxygenase-1 and −2 in human colorectal cancer. Cancer Res. 55 (1995), 3785–3789.
54. Temraz, S., Mukherji, D., Shamseddine, A., Potential targets for colorectal cancer prevention. Int. J. Mol. Sci. 14:9 (2013), 17279–17303.
55. Schrör, K., Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer. Best Prac. Res. Clin. Gastroenterol. 25 (2011), 473–484.
56. Ambs, S., Merriam, W.G., Bennett, W.P., et al. Frequent nitric oxide synthase 2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58 (1998), 334–341.
57. Moochhala, S., Chhatwal, V.J.S., Chan, S.T.F., et al. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 117 (1996), 1171–1174.
58. Kojima, M., Morisaki, T., Tsukahara, Y., et al. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J. Surg. Oncol. 70 (1999), 222–229.
59. Hofseth, L.J., Hussain, S.P., Wogan, G.N., et al. Nitric oxide in cancer and chemoprevention. Free Radic. Biol. Med. 34 (2003), 955–968.
60. Verma, A., Shukla, G., Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in Sprague Dawley rats. Nutr. Cancer 65:1 (2013), 84–91.
61. Escamilla, J., Lane, M.A., Maitin, V., Cell-Free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion In vitro. Nutr. Cancer 64:6 (2012), 871–878.